Company logo

WAT - Waters Corporation

NYSE -> Healthcare -> Diagnostics & Research
Milford, United States

WAT price evolution
WAT
(in millions $) 2 Nov 2021 30 Sep 2021 30 Jun 2021 31 Mar 2021
Current assets
Cash $524.7 $524.7 $460.06 $683.78
Short term investments $130.49 $203.57 $125.99
Net receivables $532.96 $532.96 $543.07 $550.68
Inventory $388.76 $388.76 $348.77 $327.97
Total current assets $1658.08 $1658.08 $1638.55 $1767.92
Long term investments
Property, plant & equipment $530.06 $614.91 $616.01 $602
Goodwill & intangible assets $682.83 $686.66 $678.99
Total noncurrent assets $1457.84 $1457.84 $1465.1 $1443.64
Total investments $130.49 $203.57 $125.99
Total assets $3115.91 $3115.91 $3103.65 $3211.56
Current liabilities
Accounts payable $88.9 $88.9 $83.25 $81.51
Deferred revenue $262.76 $262.76 $284.76 $280.85
Short long term debt $26.84 $27.58 $126.91
Total current liabilities $671.89 $671.89 $681.02 $785.05
Long term debt $1613.62 $1672 $1664.77 $1664.59
Total noncurrent liabilities $2148.8 $2148.8 $2154.36 $2195.55
Total debt $1698.84 $1692.35 $1791.5
Total liabilities $2820.69 $2820.69 $2835.37 $2980.6
Shareholders' equity
Retained earnings $7584.59 $7584.59 $7423.41 $7256.12
Other shareholder equity -$115.29 -$115.61 -$111.18 -$111.21
Total shareholder equity $295.22 $268.27 $230.96
(in millions $) 31 Dec 2020 31 Dec 2019 31 Dec 2018 31 Dec 2017
Current assets
Cash $436.69 $335.71 $796.28 $642.32
Short term investments $6.45 $1.43 $938.94 $2751.38
Net receivables $573.32 $587.73 $568.32 $533.83
Inventory $304.28 $320.55 $291.57 $270.29
Total current assets $1401.03 $1312.49 $2663.16 $4270.13
Long term investments $4.49 $1.09
Property, plant & equipment $587.25 $510.7 $343.08 $349.28
Goodwill & intangible assets $703.01 $596.33 $602.52 $588.21
Total noncurrent assets $1438.89 $1244.56 $1064.26 $1054.22
Total investments $6.45 $1.43 $938.94 $2751.38
Total assets $2839.92 $2557.05 $3727.43 $5324.35
Current liabilities
Accounts payable $72.21 $49 $68.17 $64.54
Deferred revenue $198.24 $176.36 $164.97 $166.84
Short long term debt $177.76 $127.49 $0.18 $100.27
Total current liabilities $804.98 $591.33 $448.93 $606.16
Long term debt $1274.71 $1647.68 $1148.17 $1897.5
Total noncurrent liabilities $1802.79 $2182 $1711.24 $2484.41
Total debt $1452.48 $1775.17 $1148.35 $1997.77
Total liabilities $2607.78 $2773.34 $2160.17 $3090.57
Shareholders' equity
Retained earnings $7107.99 $6587.4 $5995.2 $5405.38
Other shareholder equity -$117.94 -$119.47 -$117.97 -$110.07
Total shareholder equity $232.14 -$216.28 $1567.26 $2233.79
(in millions $) 2 Nov 2021 30 Sep 2021 30 Jun 2021 31 Mar 2021
Revenue
Total revenue $659.23 $659.23 $681.65 $608.54
Cost of revenue $271.13 $280.25 $254.15
Gross Profit $388.11 $388.11 $401.39 $354.4
Operating activities
Research & development $41.99 $44.95 $38.09
Selling, general & administrative $152.54 $158.21 $143.2
Total operating expenses $196.42 $196.29 $204.97 $183.13
Operating income $191.81 $191.81 $196.42 $171.27
Income from continuing operations
EBIT $193.76 $209.44 $184.73
Income tax expense $21.49 $21.49 $30.12 $25.66
Interest expense $11.08 $11.08 $12.03 $10.95
Net income
Net income $161.19 $161.19 $167.29 $148.13
Income (for common shares) $161.19 $167.29 $148.13
(in millions $) 31 Dec 2020 31 Dec 2019 31 Dec 2018 31 Dec 2017
Revenue
Total revenue $2365.36 $2406.6 $2419.93 $2309.08
Cost of revenue $1006.69 $1010.7 $992.56 $947.07
Gross Profit $1358.68 $1395.9 $1427.37 $1362.01
Operating activities
Research & development $140.78 $142.96 $143.4 $132.59
Selling, general & administrative $553.7 $534.79 $536.9 $544.7
Total operating expenses $714.96 $691.02 $735.38 $700.15
Operating income $643.71 $704.87 $691.98 $661.86
Income from continuing operations
EBIT $659.98 $726.93 $730.79 $697.94
Income tax expense $89.34 $86.04 $88.35 $620.79
Interest expense $49.07 $48.69 $48.64 $56.84
Net income
Net income $521.57 $592.2 $593.79 $20.31
Income (for common shares) $521.57 $592.2 $593.79 $20.31
(in millions $) 2 Nov 2021 30 Sep 2021 30 Jun 2021 31 Mar 2021
Net income $476.6 $161.19 $167.29 $148.13
Operating activities
Depreciation $33.18 $33.39 $31.36
Business acquisitions & disposals
Stock-based compensation $6.35 $7.29 $8.3
Total cash flows from operations $529.34 $167.89 $143.04 $218.4
Investing activities
Capital expenditures -$39.73 -$37.39 -$39.5
Investments $72.4 -$77.72 -$119.5
Total cash flows from investing -$248.43 $32.68 -$122.1 -$159
Financing activities
Dividends paid
Sale and purchase of stock -$141.22 -$139.46 -$157.01
Net borrowings $5.1 -$100 $346.36
Total cash flows from financing -$183.91 -$135.72 -$236.97 $188.78
Effect of exchange rate -$8.99 -$0.21 -$7.7 -$1.09
Change in cash and equivalents $88.01 $64.65 -$223.73 $247.09
(in millions $) 31 Dec 2020 31 Dec 2019 31 Dec 2018 31 Dec 2017
Net income $521.57 $592.2 $593.79 $20.31
Operating activities
Depreciation $125.36 $105.3 $108.41 $106
Business acquisitions & disposals -$80.55 -$31.49
Stock-based compensation $36.87 $38.58 $37.54 $39.44
Total cash flows from operations $790.51 $643.09 $604.45 $697.64
Investing activities
Capital expenditures -$172.38 -$163.82 -$96.08 -$85.47
Investments -$11.16 $932.63 $1810.87 -$445.28
Total cash flows from investing -$264.09 $768.8 $1683.3 -$535.75
Financing activities
Dividends paid
Sale and purchase of stock -$130.38 -$2415.54 -$1262.68 -$234.75
Net borrowings -$325.37 $532.26 -$850.16 $166.99
Total cash flows from financing -$440.5 -$1872.68 -$2119.52 -$63.87
Effect of exchange rate $15.07 $0.22 -$14.27 $38.67
Change in cash and equivalents $100.98 -$460.56 $153.96 $136.69
Fundamentals
Market cap $20.22B
Enterprise value N/A
Shares outstanding 61.04M
Revenue $2.61B
EBITDA N/A
EBIT N/A
Net Income $637.79M
Revenue Q/Q -16.20%
Revenue Y/Y 10.29%
P/E ratio 31.71
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio 7.75
P/B ratio N/A
Book/Share N/A
Cash/Share 8.60
EPS $10.45
ROA 20.33%
ROE N/A
Debt/Equity 11.23
Net debt/EBITDA N/A
Current ratio 2.47
Quick ratio 1.89